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Valosin-containing protein (VCP) is a highly ex-
pressed member of the type II AAA+ ATPase family.
VCP mutations are the cause of inclusion body
myopathy, Paget’s disease of the bone, and fronto-
temporal dementia (IBMPFD) and they account for
1%–2% of familial amyotrophic lateral sclerosis
(ALS). Using fibroblasts from patients carrying three
independent pathogenic mutations in the VCP
gene, we show that VCP deficiency causes profound
mitochondrial uncoupling leading to decreasedmito-
chondrial membrane potential and increased mito-
chondrial oxygen consumption. This mitochondrial
uncoupling results in a significant reduction of
cellular ATP production. Decreased ATP levels in
VCP-deficient cells lower their energy capacity,
making them more vulnerable to high energy-
demanding processes such as ischemia. Our find-
ings propose a mechanism by which pathogenic
VCP mutations lead to cell death.
INTRODUCTION
Valosin-containing protein (VCP), also referred to as p97, is
a highly expressed member of the type II AAA+ (ATPase associ-
ated with multiple activities) ATPase family. Single missense
mutations in the VCP gene are the cause of frontotemporal
dementia (IBMPFD) (Kimonis et al., 2000; Watts et al., 2004)
and may account for 1%–2% of familial amyotrophic lateral
sclerosis (ALS) (Johnson et al., 2010). However, the molecular
mechanisms by which VCP deficiency contributes to these
diseases are yet to be determined. ALS and frontotemporal
dementia (FTD) are clinically distinct disorders that have recently
been brought together with the identification of C9orf72 expan-sions and the important neuropathological overlap of cyto-
plasmic inclusions of TAR DNA binding protein 43 (TDP-43) in
both disorders.
VCP was shown to play a role in seemingly unrelated cellular
processes (for review, see Meyer et al., 2012; Yamanaka
et al., 2012). The high homology of VCP between species
(CDC48 in yeast, TER94 in Drosophila, and p97 in mouse) has
allowed the design of powerful model organisms aimed at
studying the molecular mechanisms associated with VCP
deficiency and VCP pathogenic mutations (Badadani et al.,
2010; Custer et al., 2010; Weihl et al., 2007). In particular, the
recently reported R155H/+ VCP knockin mice show extensive
accumulation of abnormal mitochondria (Nalbandian et al.,
2013; Yin et al., 2012). Mitochondria play key roles in numerous
cellular processes, including ATP production, calcium homeo-
stasis, and ultimately cell death. In no cell type is their function
more vital than in neurons, in which limited glycolysis causes
the cell to rely on oxidative phosphorylation for ATP production.
In this study, we used dynamic imaging techniques to explore
the mitochondrial pathophysiology in a VCP knockdown (VCP
KD) human dopaminergic neuroblastoma cell line (SH-SY5Y)
and in fibroblasts from patients carrying three independent
pathogenic mutations in the VCP gene. We demonstrate that
VCP deficiency induces the uncoupling of respiration from
oxidative phosphorylation. This results in decreased mitochon-
drial membrane potential, leading to higher respiration and
lower ATP levels due to reduced ATP production. These findings
define a mechanism whereby VCP dysfunction may cause
cell death and highlight pathophysiological events that may
occur in IBMPFD.
RESULTS
VCP Deficiency Is Associated with Decreased
Mitochondrial Membrane Potential
Mitochondrial membrane potential (DJm) is an indicator of
mitochondrial health and function. To study VCP implicationNeuron 78, 57–64, April 10, 2013 ª2013 Elsevier Inc. 57
Figure 1. Mitochondria Are Depolarized in
VCP-Deficient Cells
(A–C) Mitochondrial membrane potential (DJm)
was estimated by live cell imaging using TMRM
in redistribution mode (40 nM) in different cell
models. (A) SH-SY5Ys left untransfected, trans-
fected with scramble (SCR), or VCP siRNA. (B)
Patient fibroblasts carrying the VCP pathogenic
mutations R155H, R191Q, and R155C compared
to age-matched control fibroblasts (C1, C2, and
C3). (C) Mouse cortical primary neurons and
astrocytes transiently transduced with SCR or
VCP shRNA. (D) Images from neurons trans-
duced with GFP SCR shRNA or GFP VCP KD
shRNA (green, GFP; red, TMRM). Scale bar
represents 44 mm; in inset images, scale bars
represent 6.3 mm and 5.5 mm for SCR and VCP
KD, respectively. (E) DJm was measured in the
SH-SY5Y cells overexpressing WT or mutant
VCP. (F) DJm was measured in stable SCR and
VCP KD SH-SY5Y cells left untransfected,
overexpressing WT, or mutant VCP. In each
experiment, data were normalized to control
SCR cells (A, C, and F), control fibroblasts (B),
and WT VCP overexpressing cells (E) and are
represented as the mean ± SEM from at least
three independent experiments (*p < 0.05; **p <
0.01; ***p < 0.005 compared with control cells as
calculated by one-way ANOVA). See also
Figures S1 and S2.
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VCP Deficiency Causes Mitochondrial Uncouplingin mitochondrial function, we transiently silenced the VCP
gene using siRNA in SH-SY5Y human neuroblastoma cells
(see Figure S1A available online) and shRNA in mouse primary
cortical cultures (Figure 1D). Additionally, stable populations
of VCP KD SH-SY5Y cells were generated using shRNA (Fig-
ure S1B). DJm was measured in VCP-deficient SH-SY5Y cells
(Figure 1A), in human fibroblasts from three patients with
independent VCP mutations (R155C, R155H, and R191Q; for
donors’ details see Figure S1E and Table S1) and age-
matched controls (Figure 1B), and in primary neurons and
astrocytes (Figures 1C and 1D). A significant decrease in
DJm was observed in all VCP-deficient cell models studied
(SH-SY5Y cells = 72% ± 8%, n > 20 cells in 3 independent
experiments compared to either untransfected cells or cells
transfected with scramble (SCR) control siRNA; primary
neurons = 62% ± 9% and primary astrocytes = 74% ± 4%,
n R 5 cells in 3 independent experiments compared to cells
transfected with SCR control shRNA; fibroblasts from patient
1 = 86% ± 2%, n = 7; fibroblasts from patient 2 = 85% ±
2%, n = 8; fibroblasts from patient 3 = 91% ± 2%, n = 5,
compared to age-matched control fibroblasts) (Figures 1A–
1C). Overexpression of R155H, R191Q, and R155C VCP
mutants in SH-SY5Y cells is associated with a significant
reduction in the TMRM signal (TMRM in cells overexpressing
R155H VCP = 73% ± 3%; R191Q VCP = 65% ± 3%;58 Neuron 78, 57–64, April 10, 2013 ª2013 Elsevier Inc.R155C VCP = 62% ± 13% compared
to overexpressed WT VCP; n R 3), con-
firming that the three pathogenic VCP
mutations have a dominant-negativeeffect (Figure 1E). Re-expression of WT, but not mutant
VCP, rescued the TMRM signal in a clonal population of
stable VCP KD SH-SY5Y cells (untransfected cells = 61% ±
9%; WT VCP = 97% ± 7%; R155H VCP = 62% ± 4%;
R191Q VCP = 60% ± 1%; R155C VCP = 74% ± 5%
compared to SCR SH-SY5Y control cells; n R 3) (Figures 1F
and S1D).
In healthy cells, DJm is maintained by mitochondrial respira-
tion. Upon respiratory dysfunction, cells may maintain DJm
using ATP hydrolysis by the ATP synthase (reviewed in Nicholls,
2002). In order to investigate the mechanism of maintenance of
DJm, a series of mitochondrial toxins were applied and their
effects on DJm were observed. All control cells and VCP
KD SH-SY5Y cells showed no significant response to the
F1F0-ATP synthase inhibitor oligomycin (0.2 mg/ml), while subse-
quent inhibition of complex I by rotenone (5 mM) caused a rapid
loss of potential (Figure S2A). However, application of oligomy-
cin to patient fibroblasts carrying VCP mutations resulted in
a modest depolarization, suggesting that complex V may be
partially working in reverse mode in these cells, in order to main-
tain the DJm (Figure S2B). Application of rotenone (5 mM) to
inhibit complex I then generated a strong depolarization.
Complete depolarization was assessed in all cell models by
addition of the mitochondrial uncoupler carbonylcyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) (1 mM) (Figure S2B).
Figure 2. Mitochondrial Respiration Is
Increased in VCP-Deficient Cells
(A–C) NADH redox indexes were obtained after
monitoring NADH autofluorescence in VCP-defi-
cient cells compared to control cells. (A) Repre-
sentative experiments of NADH autofluorescence
from untransfected, SCR, and VCP KD cells
(mean ± SEM of at least 20 cells on a single
coverslip) in which the NADH redox index (the
initial redox level expressed as percentage of the
range) is described graphically (left). NADH redox
indexes were obtained by calculating the initial
NADH autofluorescence when the minimum
NADH autofluorescence after FCCP (1 mM) addi-
tion is normalized to 0% and the maximum to
100% after addition of NaCN (1 mM). (B) NADH
redox indexes from untransfected, SCR, and VCP
KD SH-SY5Y cells. (C) NADH redox indexes from
control and VCP-deficient fibroblasts. (D and E)
FAD autofluorescence was monitored by confocal
microscopy in untransfected, SCR, and VCP KD
SH-SY5Y cells. (D) Representative experiments of
FAD autofluorescence from untransfected, SCR,
and VCP KD cells (mean ± SEM of at least 20 cells
on a single coverslip) in which the FAD/redox index
(the initial redox level expressed as percentage of
the range) is described graphically (left). FAD
redox indexes were obtained by calculating the
initial FAD autofluorescence after normalizing the
FCCP (1 mM) response to 100% (maximum respi-
ration) and the NaCN (1 mM) response to 0%
(minimum respiration). (E) FAD redox indexes
from untransfected, SCR, and VCP KD SH-SY5Y
cells. In all cases, error bars represent the mean ±
SEM of at least three independent experiments
(**p < 0.01; ***p < 0.005, compared with control
cells as calculated by one-way ANOVA).
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VCP Deficiency Causes Mitochondrial UncouplingTaken together, these data suggest that DJm is mainly main-
tained by respiration in VCP-deficient cells.
Mitochondrial Respiration Is Increased in
VCP-Deficient Cells
The redox state of NADH or FAD reflects the activity of the
mitochondrial electron transport chain (ETC) and the rate of
substrate supply. We measured the basal levels of NADH
(substrate for the ETC complex I) and FAD autofluorescence
and generated the ‘‘redox indexes’’ by expressing basal NADH
or FAD levels as a percentage of the difference between
the maximally oxidized and maximally reduced signals.
The maximally oxidized signal is defined as the response to
1 mM FCCP that stimulates maximal respiration, while the
maximally reduced signal is defined as the response to 1 mM
NaCN that fully inhibits respiration. Figure 2A shows averageNeuron 78, 57traces for NADH autofluorescence in
untransfected, SCR, and VCP KD SH-
SY5Y cells. The NADH redox index
generated was significantly lower in
transient VCP KD SH-SY5Y cells
(17% ± 2%, n = 8) compared to control
untransfected (28% ± 3%, n = 8)and SCR-transfected (29% ± 3%, n = 8) cells (Figure 2B), indi-
cating a depletion of NADH under basal conditions. NADH redox
index in patient fibroblasts was also lower than in the
age-matched controls (patient 1 = 49% ± 7%, n = 9; patient
2 = 48% ± 8%, n = 8; patient 3 = 43% ± 9%, n = 10; control
1 = 84% ± 10%, n = 7; control 2 = 66% ± 7%, n = 7; control
3 = 83% ± 9%, n = 8) (Figure 2C).
We then measured the FAD autofluorescence in SH-SY5Y
cells. Figure 2D shows average traces for FAD in untrans-
fected, SCR, and VCP KD SH-SY5Y cells. The generated
FAD redox index was significantly higher in transient VCP
KD SH-SY5Y cells (75% ± 13%, n = 4) compared to control
untransfected (21% ± 5%; n = 4) and SCR-transfected (32% ±
4%; n = 4) cells (Figure 2E). We were unable to measure the
FAD redox state in fibroblasts due to the very low level of
FAD autofluorescence in these cells.–64, April 10, 2013 ª2013 Elsevier Inc. 59
Figure 3. Oxygen Consumption Is Increased in VCP-Deficient Cells
(A–C) Oxygen consumption was measured in intact SH-SY5Y cells using
a Clark oxygen electrode. (A) Basal respiration (Vbasal) was measured in stable
SCR and VCP KD cells (clones V#2, V#3, and Pool). ATP production was then
inhibited using oligomycin (0.2 mg/ml) (Voligomycin) to obtain the minimal respi-
ration. Maximized respiration was monitored by adding the uncoupler FCCP
(1 mM) (VFCCP). (B) Vbasal/Voligomycin index was generated to determine the level
of coupling between respiration and oxidative phosphorylation in SCR and
VCP KD cells. (C) Vbasal/VFCCP index was generated to verify the function of
ETC complexes of SCR and VCP KD SH-SY5Y cells. (D and E) Stable SCR and
VCP KD cells (clones V#1, V#2, V#3, V#4, and Pool) were permeabilized and
oxygen consumption was measured in state 3 (V3) (in which 50 nmol ADP were
provided) and state 4 (V4) (in which no ADP is present). (D) The respiratory
control ratio (RCR), a ratio of V3 to V4, was then generated. (E) The ADP
consumed per atom of oxygen (ADP/O) was also determined. The experiment
was performed in the presence of substrates for complex I (5 mM of glutamate
and malate). Data are represented as mean ± SEM from at least three inde-
pendent experiments (n/s = nonsignificant differences; *p < 0.05; **p < 0.01
compared with values from SCR cells). See also Tables S2 and S3.
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VCP Deficiency Causes Mitochondrial UncouplingOxygen Consumption Is Increased in
VCP-Deficient Cells
Both the decrease in NADH autofluorescence and the loss of
DJm observed in the VCP-deficient cells could reflect either an
increased mitochondrial proton leak and uncoupling, in which
case oxygen consumption would be increased in these cells,
or a lack of substrates, in which case it would be decreased.
The rate of oxygen consumption was thus measured using
a Clark oxygen electrode in three clonal populations of stable60 Neuron 78, 57–64, April 10, 2013 ª2013 Elsevier Inc.VCP KD SH-SY5Y cells. VCP protein expression levels were
reduced by approximately 90% in stable VCP KD SH-SY5Y
cells compared to stable SCR SH-SY5Y cells (Figure S1B). The
basal rate of oxygen consumption was significantly increased
in VCP KD cells compared to control (Figure 3A; for numbers
see Table S2). Furthermore, addition of oligomycin resulted in
an inhibition of oxygen consumption in control cells but not in
VCP KD cells, while the uncoupler FCCP increased oxygen
consumption to the same maximal values in both cell popula-
tions. Calculation of Vbasal/Voligomycin and Vbasal/VFCCP revealed
a decrease in the Vbasal/Voligomycin index, suggesting an increase
in mitochondrial respiration (Figure 3B; for numbers see Table
S2). No differences in the Vbasal/VFCCP index were observed
between VCP KD and SCR cells, showing that ETC complexes
are not damaged and they are working at a similar rate under
normal conditions (Figure 3C; for numbers see Table S2).
To further analyze ETC and OXPHOS functionality and
coupling, we permeabilized stable VCP KD and SCR cell lines
using a low concentration of digitonin (40 mM) and basal oxygen
consumption rates were measured in the presence of external
substrates for the ETC in the absence of ADP. We then added
50 nmol ADP to establish state 3 (V3) respiration. Upon
consumption of this ADP, mitochondria resumed an inhibited
state, termed state 4 (V4). Respiratory control ratio (RCR) is the
ratio of V3 to V4 and is considered an indicator of coupling of
OXPHOS and respiration. RCR values confirmed the uncoupling
of mitochondrial respiratory chain from oxidative phosphoryla-
tion in stable VCP KD cells compared to control (Figure 3D; for
numbers see Table S3). The ‘‘ADP/O’’ ratio, expressed as the
oxygen consumed per nmol ADP added during V3, indicates
the efficiency of oxidative phosphorylation. ADP/O ratios indi-
cated that oxidative phosphorylation efficiency was reduced
by more than 30% in VCP KD cells compared to SCR cells (Fig-
ure 3E; for numbers see Table S3). Taken together, these data
show that the respiratory rate, driven by the loss of potential
and oxidation of the NADH pool, is increased in VCP-deficient
cells and that VCP deficiency increases themitochondrial proton
leak causing uncoupling between respiration and OXPHOS.
Mitochondrial uncoupling may occur through a variety of
mechanisms including altered lipid peroxidation. Using the fluo-
rescent ratiometric oxidation-sensitive dye C11 BODIPY581/
591, we therefore determined the levels of lipid peroxidation in
VCP-deficient cells. The assay is based on the observation
that oxidation of the dye by peroxyl radicals causes a shift in
fluorescence emission from red to green. Figure S3A shows
the green/red fluorescence ratios over time in a single experi-
ment, while Figure S4B shows the average rate of increase in
green/red fluorescence over three independent experiments.
Fibroblasts carrying VCP mutations exhibit similar lipid peroxi-
dation rates when compared to controls (Figures S3A–S3C).
These results suggest that uncoupling in these cells is not related
to changes or alterations in lipid peroxidation rates.
ATP Levels Are Decreased in VCP-Deficient Cells
Basal cellular ATP levels are determined by the rates of ATP
production (oxidative phosphorylation and glycolysis) and
consumption. To monitor ATP levels in live VCP-deficient
cells, we used a FRET-based ATP sensor. In a first subset of
Figure 4. Lower ATP Production Reflects
Lower ATP Levels in VCP-Deficient Cells
(A–C) ATP levels in untransfected, SCR, and VCP
KD SH-SY5Y cells were measured using a FRET-
based method by transfection of the ATP indicator
AT1.03. Cells were subjected to imaging and ratio-
metric analysis of the yellow- (YFP) and cyan-
(CFP) fluorescent proteins, allowing estimation of
ATP kinetics within single cells by confocal
microscopy. ATP levels from glycolysis or from
oxidative phosphorylation are described graphi-
cally (A, left). (A) Representative experiments of
time-dependent YFP/CFP ratios from un-
transfected, SCR, and VCP KD cells (mean ± SEM
of at least 10 cells on a single coverslip). The initial
YFP/CFP ratio was obtained when no ATP
synthesis was inhibited, once glycolysis was in-
hibited with iodoacetic acid (IAA, 100 mM) and after
inhibition of ATPase with oligomycin (0.2 mg/ml) (A,
left). (B) Quantified ATP levels from glycolysis (dark
gray bars) or from oxidative phosphorylation
(white bars). (C) ATP levels in fibroblasts were
measured using a bioluminescent assay based
on the luciferin-luciferase system. (D) ATP con-
sumption/production levels were assessed by
using the Mg2+-sensitive fluorescent probe Mag-
Fura. ATP depletion and time of cell lysis are
described graphically (D, left). Representative
traces from control (left) and patient fibroblasts
(right) after inhibition of respiration and glycolysis.
(E) Energy capacity as seen as time to cell lysis in
response to inhibition of ATP synthesis (both
glycolysis with IAA and oxidative phosphorylation
with oligomycin) compared to control values ex-
pressed as percentages. The panel shows the
ATP consumption in fibroblasts. (F) Energy
capacity as seen as time to cell lysis in response to
NaCN (1 mM) and IAA (0.2 mM) compared to
control values expressed as percentage. The
panel shows the ATP production in fibroblasts. In
all cases, the error bars represent the mean ± SEM
of at least three independent experiments carried
out in triplicate (n/s = nonsignificant differences;
*p < 0.05; **p < 0.01; ***p < 0.005 compared with
control values). See also Figure S4.
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VCP Deficiency Causes Mitochondrial Uncouplingexperiments, control and VCP KD SH-SY5Y cells were
treated with 100 mM glycolytic inhibitor iodoacetic acid (IAA) to
monitor the ATP levels generated from glycolysis and then with
0.2 mg/ml oligomycin to determine the ATP levels generated
by the ATP synthase (Figures 4A, 4B, and S4A). In a second
group of measurements, ATP synthase was inhibited prior to
inhibition of glycolysis (Figure S4B). In all experiments, basal
ATP levels were measured prior to treatment with inhibitors.
Figure 4A shows traces from a representative experiment in
which ATP levels were measured in untransfected, SCR, and
VCP KD cells. The relative ATP levels generated by glycolysis
and the ATP synthase as seen as a reduction in the YFP/CFP
ratio after addition of inhibitors are represented in Figure 4B. A
not statistically significant decrease in ATP levels was observed
in VCP KD cells after inhibition of glycolysis by IAA (Figures 4B
and S4A). However, ATP levels were significantly lower in VCPKD cells compared to controls after inhibition of ATP synthase
by oligomycin (Figure 4B and S4A) (YFP/CFP: untransfected =
0.21 ± 0.07, n = 3; SCR = 0.30 ± 0.05, n = 4; VCP KD = 0.04 ±
0.01, n = 4). Interestingly, when glycolysis was inhibited
after ATP synthase, control and VCP KD SH-SY5Y cells
showed no decrease in ATP levels in response to IAA (Fig-
ure S4B). Due to the low efficiency of transfection in primary
patient fibroblasts, a bioluminescent assay based on the
luciferin-luciferase system was used to detect the ATP levels in
these cells. In all three patient fibroblast lines, ATP levels were
significantly decreased compared to age-matched control fibro-
blasts (luminescence arbitrary units: patient 1 = 0.63 ± 0.05, n =
7; patient 2 = 0.66 ± 0.07, n = 5; patient 3 = 0.53 ± 0.09, n = 7;
control 1 = 0.90 ± 0.09, n = 7; control 2 = 0.91 ± 0.03, n = 6;
control 3 = 0.90 ± 0.06, n = 4) (Figure 4C). These experiments
show that VCP pathogenic mutations also lead to decreasedNeuron 78, 57–64, April 10, 2013 ª2013 Elsevier Inc. 61
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VCP Deficiency Causes Mitochondrial UncouplingATP levels. The energy capacity was then measured in VCP-
deficient fibroblasts to determine the cause of low ATP levels
in these cells. The energy capacity of a cell is defined as the
time between application of inhibitors of glycolysis/ATP-
synthase (i.e., cessation of ATP production) and the time of cell
lysis (i.e., energetic collapse due to total ATP depletion and
inability to maintain Ca2+ homeostasis) (Yao et al., 2011) (Fig-
ure 4D). The ATP consumption rates were estimated by
measurement of the energy capacity after inhibition of glycolysis
and F1F0-ATP synthase with IAA (100 mM) and oligomycin
(0.2 mg/ml), respectively, showing no differences between
patient and control fibroblasts (Figure 4E). However, the ATP
production rates in patient fibroblasts monitored by inhibition
of glycolysis (IAA, 100 mM) and respiration (NaCN, 1 mM) were
found to be significantly decreased compared to controls (Fig-
ure 4F) (energy capacity: patient 1 = 41% ± 6%; patient 2 =
55% ± 8%; patient 3 = 60% ± 6%; control 1 = 100% ± 0%;
control 2 = 88% ± 12%; control 3 = 86% ± 8%; n = 3). These
results show that VCP-deficient cells generate less ATP than
control cells but also demonstrate the vulnerability of these cells
to chemical ischemia (Figure 4F).
DISCUSSION
As the energy factories of the cells, mitochondria play a vital
role in neurons, in which oxidative phosphorylation is the main
source of ATP. Previous studies have shown that pathogenic
VCP mutations modulate VCP ATPase activity in vitro (Halawani
et al., 2009) and that they are associated with altered cellular
ATP levels in Drosophila (Chan et al., 2012; Chang et al., 2011;
Manno et al., 2010). In this study, we investigated the mitochon-
drial bioenergetics in VCP-deficient cells and in fibroblasts with
VCP mutations from IBMPFD patients. We show that loss of
VCP function is associated with decreased DJm in the above
cell models and in mouse cortical primary neurons and astro-
cytes. VCP deficiency further results in increased mitochondrial
respiration and uncoupling. These observations are accompa-
nied by decreased ATP levels due to lower ATP production.
A number of prior studies have observed alteredmitochondrial
respiratory complex function in ALS disease models including
postmortem brain and spinal cord tissue (Bowling et al., 1993;
Wiedemann et al., 2002), patient lymphocytes (Ghiasi et al.,
2012), and a transgenic mouse model of ALS (Jung et al.,
2002). Despite these findings, there remains some controversy
surrounding the dysfunction of mitochondrial respiratory chain
complexes in ALS, and we previously found normal activity in
muscle, myoblasts, fibroblasts, and cybrids from patients (Brad-
ley et al., 2009). Accordingly, our results strongly suggest that
there is no impairment of mitochondrial respiratory complexes
in any of the fibroblasts from the IBMFPD patients carrying
the VCP pathogenic mutations.
We observed thatDJmwas decreased in all the VCP-deficient
cell models.DJm is a key indicator of mitochondrial viability, as it
reflects the pumping of hydrogen ions across the inner mem-
brane during the process of electron transport, the driving force
behind ATP production. We showed that VCP-deficient cells are
still able to maintain their DJm through respiration, since addi-
tion of oligomycin, the inhibitor of the F1F0-ATP synthase,62 Neuron 78, 57–64, April 10, 2013 ª2013 Elsevier Inc.induced no response in VCP KD cells or a slight depolarization
in patient fibroblasts. These data suggest that while DJm is
largely maintained by respiration in both SH-SY5Y cells and
patient fibroblasts, in patient fibroblasts carrying VCPmutations,
ATPase may be required to work in its reverse mode hydrolysing
ATP in order to maintain the DJm.
In combination with low DJm, we observed decreased NADH
redox index in our VCP-deficient cell models compared to
control cells, indicating increased respiration. These results are
consistent with the higher oxygen consumption rates and lower
RCR values obtained in VCP-deficient cells, indicating mito-
chondrial uncoupling between respiration and oxidative phos-
phorylation. In agreement with these observations, ADP/O
values were lower in VCP-deficient cells, confirming that the
oxidative phosphorylation efficiency is decreased in these cells.
In order to compensate for the accumulation of uncoupled mito-
chondria, cells may stimulate mitochondrial biogenesis (for
review, see Perez-Pinzon et al., 2012). However, no difference
in mitochondrial mass was observed in our VCP-deficient neuro-
blastoma cells compared to controls (Figure S3), suggesting that
the uncoupling observed in these cells is due to physiological
rather than structural mitochondrial abnormalities.
Mitochondrial uncoupling has previously been observed in
different models of neurodegeneration (Papkovskaia et al.,
2012; Plun-Favreau et al., 2012; White et al., 2011). It may be
induced via various mechanisms including altered mitochondrial
membrane integrity due to excessive lipid peroxidation-derived
free radical production (Brookes et al., 1998; Chen and Yu,
1994). Here we show that lipid peroxidation levels are not altered
in VCP-deficient cells, indicating that uncoupling is unlikely to
occur through thismechanism in these cells. Alternative possibil-
ities include that VCPdeficiency is associatedwith aderegulation
of the uncoupling proteins (UCPs) or the adenine nucleotide
translocase (ANT1), both of which play an important role in
regulating the coupling of mitochondrial respiratory chain to
oxidative phosphorylation. Interestingly, the levels of UCPs,
key regulators of mitochondrial function, have previously been
shown to be altered in skeletal muscle biopsies from rat and
mouse ALS models and human ALS patients (Dupuis et al.,
2003; Patel et al., 2010; Smittkamp et al., 2010). Further experi-
mental investigation is required to determine whether altered
levels or function of UCPs are observed in VCP-deficient cells.
UCPs could dissipate the proton gradient, generated in the
intermembrane space by the increased respiration observed
in VCP-deficient cells, into heat. ANT1 was also found to be
highly expressed in a transgenic mouse model of ALS (Martin
et al., 2009). This ADP/ATP translocase is responsible for the
transport of adenine nucleotides across the mitochondrial inner
membrane, but it is also thought to have an intrinsic uncoupling
property (Brand et al., 2005). Under healthy conditions, the DJm
generated by respiration is used by ANT1 for translocation of
cytosolic ADP to the mitochondrial matrix and further generation
of ATP. A slight increase in oxygen consumption when ADP was
added in permeabilized cells points to a possible deregulation in
the ADP/ATP translocase induced by the VCP deficiency.
Further physiological and biochemical experiments will be
necessary to determine the possible roles of UCPs and ANT1
in the VCP-deficient cells.
Neuron
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polarized mitochondria through selective autophagy (Tanaka
et al., 2010), raising the possibility that loss of VCP mutations
allows the accumulation of damaged, uncoupled mitochondria
that would usually be degraded. However, genetic mutations in
other members of this pathway (PINK1 and Parkin) lead to
a markedly different phenotype in patients (Vincent et al., 2012;
Yao et al., 2011) and mitochondrial uncoupling has not been re-
ported in cells lacking either protein, suggesting a more direct
role for VCP in the mitochondrial uncoupling we observe.
A number of studies in different ALS models have linked mito-
chondrial deficiency and altered ATP levels to the pathogenesis
of the disease (Ghiasi et al., 2012; Mattiazzi et al., 2002). Browne
and colleagues have suggested that the decreased ATP levels
they observed in ALS transgenic mice could be due to uncou-
pling (Browne et al., 2006) and IBMPFD-causing VCPmutations
were associated with altered ATP levels in Drosophila (Chang
et al., 2011). Here we further confirm that VCP mutations lead
to reduced ATP levels in patient fibroblasts carrying three inde-
pendent pathogenic mutations, and we show that this is the
result of lower ATP production rather than higher ATP consump-
tion. In VCP-deficient flies, on the other hand, altered ATP
levels were suggested to be the result of higher rates of ATP
consumption (Chan et al., 2012; Chang et al., 2011). These
discrepancies could reflect the different metabolism between
flies and mammals and may be further explained by the use of
different research methods. ATP depletion was previously
shown to induce cytotoxicity, as the cells are no longer able to
maintain their ionic homeostasis and flood with calcium (re-
viewed by Abramov and Duchen, 2010; Bolan˜os et al., 2009).
Our data confirm that VCP-deficient fibroblasts are more vulner-
able to cytotoxicity than control cells after depletion of ATP.
Together, our results suggest that the pathogenic VCP muta-
tions have a dominant-negative effect that presumably arises
from a loss of function of the hexameric protein through
poisoning by the mutant subunits. The DJm measurement
carried out in SH-SY5Y cells overexpressing VCP WT or
pathogenic mutants as well as the rescue experiment in the
stable VCP KD SH-SY5Y cells (Figures 1E and 1F) strengthen
this hypothesis. This inhibitory effect of the mutant subunits
on the wild-type subunits has previously been shown for Torsin
A, another member of the AAA ATP-ase family and its torsin
dystonia-associated mutants (Goodchild et al., 2005). Two of
the VCP mutations harbored by the patient fibroblasts are
located at the N domain of the protein (R155H and R155C),
whereas the third one is located in the link between the N and
the D1 domain (R191Q). It was previously shown that none
of IBMPFD mutations in VCP disrupt gross hexamer formation
(Halawani et al., 2009).
Themitochondrial dysfunction observed in this studymay help
to explain the myopathic phenotype of VCP patients. Dementia
is unusual in mitochondrial disorders, but mitochondrial dys-
function has also been suggested to be important in a number
of central degenerative disorders such as SOD1-associated
ALS (for review, see Dupuis et al., 2003).
In summary, we have characterized the mitochondrial
pathology in fibroblasts from IBMFPD patients carrying VCP
mutations and identified a possible mechanism of neurotoxicity.Our data suggest that VCP deficiency leads to severe mitochon-
drial uncoupling, resulting in decreased ATP production and
subsequent depletion of cellular ATP. This lack of ATP in turn
renders VCP-deficient cells significantly more vulnerable to
cytotoxicity in response to any further inhibition of mitochondrial
respiration, andwepropose that it is this vulnerability to ischemic
conditions that may ultimately cause the neuronal death
observed in the IBMFPD patients.EXPERIMENTAL PROCEDURES
Detailed Experimental Procedures can be found in the Supplemental Experi-
mental Procedures. All samples were collected with the written consent of
participants and formal ethical approval from the National Hospital for
Neurology and Neurosurgery–Institute of Neurology Joint Research Ethics
Committee (London, UK).SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.02.028.
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